#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Breast cancer metastatic Hepatocellular carcinoma Dermatitis atopic Malignant melanoma Non-small cell lung cancer metastatic Type 2 diabetes mellitus Chronic lymphocytic leukaemia More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Glycogen storage disease type I Non-renal cell carcinoma of kidney B-cell lymphoma refractory Gastric cancer Transitional cell cancer of the renal pelvis and ureter CDKL5 deficiency disorder Haemophilia A with anti factor VIII Indolent systemic mastocytosis Fungal infection Pyoderma gangrenosum Hereditary angioedema Cutaneous T-cell lymphoma Drug eruption Hyperchylomicronaemia Cytomegalovirus infection More trials…

    Learn about Rare Diseases

    Mantle cell lymphoma – Treatment Atypical haemolytic uraemic syndrome – Diagnostics Langerhans’ cell histiocytosis – Life with Disease Shprintzen-Goldberg syndrome Paroxysmal nocturnal haemoglobinuria – Trials in Disease Thrombotic thrombocytopenic purpura – Basic Information Richter’s syndrome – Trials in Disease Gastrointestinal stromal tumour – Diagnostics Mucous membrane pemphigoid – Trials in Disease Krabbe’s disease – Life with Disease More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Goserelin Mbf-118 Lidocaine Vortioxetine Chlorphenamine Maleate Pantoprazole Amoxicillin Sodium Bempedoic Acid Topiramate Iomeprol Thiotepa Vilobelimab Salbutamol Psma-11 Metolazone Azilsartan Medoxomil Tobramycin Bictegravir Valganciclovir Hydrochloride Pristinamycin More therapies…

    Learn about Your Condition

    Myocarditis Meniere's disease Factor VIII deficiency Osteomyelitis Pulmonary fibrosis Bronchostenosis Tooth loss Alport's syndrome Lymphangioma Pulmonary tuberculosis Medication overuse headache Haematological infection Seizure Round cell liposarcoma Cerebellar ataxia More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Slovenia

  • Study of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease

    Not recruiting

    1 1 1
    Investigated drugs:
    • Inclisiran
    • Rosuvastatin
    • Atorvastatin
    Austria Belgium Bulgaria Croatia Czechia Denmark +18
  • Study on the Effectiveness and Safety of Iptacopan for Adults with Atypical Hemolytic Uremic Syndrome Not Previously Treated with Complement Inhibitors

    Not recruiting

    1 1 1
    Investigated drugs:
    • Iptacopan
    Austria Czechia Greece Slovakia Slovenia
  • Study of Pembrolizumab for Patients with Early Stage Non-Small Cell Lung Cancer After Surgery and Standard Therapy

    Not recruiting

    1 1 1
    Investigated diseases:
    • Non-small cell lung cancer
    Investigated drugs:
    • Pembrolizumab
    Austria Belgium Czechia Denmark Estonia France +11
  • Study on Ofatumumab for Patients with Relapsing Multiple Sclerosis Transitioning from Fumarate-Based Therapies or Fingolimod

    Not recruiting

    1 1 1 1
    Investigated diseases:
    • Multiple sclerosis relapse
    Investigated drugs:
    • Ofatumumab
    Bulgaria Germany Latvia Poland Portugal Slovakia +2
  • Study on Long-term Safety and Efficacy of Cipaglucosidase Alfa and Miglustat for Adults with Late-onset Pompe Disease

    Not recruiting

    1 1 1
    Investigated drugs:
    • Miglustat
    • Cipaglucosidase Alfa
    Belgium Denmark France Greece Hungary Italy +3
  • Study Comparing Somapacitan and Somatropin for Growth in Children with Short Stature Due to Small for Gestational Age, Turner Syndrome, Noonan Syndrome, or Idiopathic Short Stature

    Not recruiting

    1 1 1 1
    Investigated diseases:
    • Small for dates baby
    • Short stature
    • Noonan syndrome
    Investigated drugs:
    • Somatropin
    • Somapacitan
    Austria Belgium Bulgaria Croatia Finland France +10
Previous Page
1 … 13 14 15 16 17
Next Page

Find Clinical Trials in Your Selected Region and City

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Sodium Chloride Semaglutide Lutikizumab Risankizumab Cyclophosphamide Guselkumab Carboplatin Iptacopan Vincristine Sulfate Dapagliflozin Pembrolizumab Empasiprubart Vedolizumab Doxorubicin Etoposide Somatropin Bi 1015550 Somapacitan 1-[[(5R)-2-[4-(5-Chloro-2-Pyrimidinyl)-1-Piperidinyl]-6,7- Dihydro-5-Oxidothieno[3,2-D]Pyrimidin-4- Yl]Amino]-Cyclobutanemethanol Pelacarsen Golimumab Efanesoctocog Alfa Atezolizumab (S)-2-Amino-6-(2-Hydroxypropanoyl)-7,8-Dihydropteridin-4(3H)-One Temozolomide Fludarabine Dexamethasone Remibrutinib Bhv-7000 Cisplatin Show more

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

Acquired antithrombin III deficiency Acute myeloid leukaemia Acute myocardial infarction Amyotrophic lateral sclerosis Anal incontinence Antibiotic therapy Arteriosclerosis Asthma Atypical haemolytic uraemic syndrome B-cell type acute leukaemia Breast cancer Cardiac failure Cardiogenic shock Chronic inflammatory demyelinating polyradiculoneuropathy Colitis ulcerative Colon cancer Critical illness Crohn's disease Cytomegalovirus infection Dementia Alzheimer's type Dermatitis atopic Duchenne muscular dystrophy Endocrine ophthalmopathy Endometrial cancer Endometrial cancer metastatic Erythema migrans Factor IX deficiency Factor VIII deficiency Fallopian tube cancer Glycogen storage disease type II Growth hormone deficiency Heparin resistance Hidradenitis Hormone receptor positive breast cancer Hormone receptor positive HER2 negative breast cancer Hormone-dependent prostate cancer Human epidermal growth factor receptor negative Hyperlipidaemia Hypertension Idiopathic pulmonary fibrosis IgA nephropathy Interstitial lung disease Kidney transplant rejection Malignant glioma Malignant melanoma Multifocal motor neuropathy Multiple sclerosis Multiple sclerosis relapse Myocarditis Myocarditis post infection Neonatal alloimmune thrombocytopenia Neuroblastoma Neurodevelopmental disorder Non-small cell lung cancer Non-small cell lung cancer stage III Noonan syndrome Obesity Ovarian cancer Pancreatic carcinoma metastatic Partial seizures Phenylketonuria Plasma cell myeloma refractory Prostate cancer Psoriatic arthropathy Pulmonary embolism Relapsing multiple sclerosis Relapsing-remitting multiple sclerosis Rhabdomyosarcoma Secondary progressive multiple sclerosis Short stature Sjogren's syndrome Small for dates baby Squamous cell carcinoma of head and neck Turner's syndrome Type 1 diabetes mellitus Type 2 diabetes mellitus Type IIa hyperlipidaemia Vascular malformation Viral myocarditis

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!